BioAssay Works is Discovery Tools (Healthcare) in United States that focus on nanoparticle gold products business. Founded in 2005. They cover business area such as developer, nanoparticle, gold product, immunodetection product, service, crucial reagent, gold sol, gold conjugate, gold ribbon, any high-performance lateral-flow device, user, quick positive/negative result, simple instrument, more quantitative result.
2005
( 19 years old in 2024 )
Nanoparticle Gold Products
-
10075 Tyler Place
Suite 18
Ijamsville, MD 21754
United States
Private
developernanoparticlegold productimmunodetection productservicecrucial reagentgold solgold conjugategold ribbonany high-performance lateral-flow deviceuserquick positive/negative resultsimple instrumentmore quantitative result
* We use standard office opening hours in near BioAssay Works's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
BioAssay Works is Discovery Tools (Healthcare) business from United States that founded in 2005 (19 years old in 2024), BioAssay Works business is focusing on Nanoparticle Gold Products.
BioAssay Works headquarter office and corporate office address is located in 10075 Tyler Place Suite 18 Ijamsville, MD 21754 United States.
BioAssay Works was founded in United States.
In 2024, BioAssay Works is currently focus on nanoparticle gold products sector.
Above is snippet of Google Trends for "nanoparticle gold products" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with BioAssay Works, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
